Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced CancersPatricia LoRusso, Alejandro D. Ricart, Lisle M. Nabell et al.|Clinical Cancer Research|2010Cited by 250
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoidRonald M. Bukowski, Catherine M. Tangen, Robert F. Peterson et al.|Cancer|1994Cited by 89